Correlation Between Wuhan Yangtze and Shanghai Rightongene

Can any of the company-specific risk be diversified away by investing in both Wuhan Yangtze and Shanghai Rightongene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Wuhan Yangtze and Shanghai Rightongene into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Wuhan Yangtze Communication and Shanghai Rightongene Biotechnology, you can compare the effects of market volatilities on Wuhan Yangtze and Shanghai Rightongene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Wuhan Yangtze with a short position of Shanghai Rightongene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Wuhan Yangtze and Shanghai Rightongene.

Diversification Opportunities for Wuhan Yangtze and Shanghai Rightongene

0.76

Correlation Coefficient

Wuhan Yangtze  Shanghai Rightongene

Poor diversification

The 3 months correlation between Wuhan and Shanghai is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Wuhan Yangtze Communication and Shanghai Rightongene Biotechno in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shanghai Rightongene and Wuhan Yangtze is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Wuhan Yangtze Communication are associated (or correlated) with Shanghai Rightongene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shanghai Rightongene has no effect on the direction of Wuhan Yangtze i.e., Wuhan Yangtze and Shanghai Rightongene go up and down completely randomly.

Pair Corralation between Wuhan Yangtze and Shanghai Rightongene

Assuming the 90 days trading horizon Wuhan Yangtze Communication is expected to under-perform the Shanghai Rightongene. But the stock apears to be less risky and, when comparing its historical volatility, Wuhan Yangtze Communication is 1.2 times less risky than Shanghai Rightongene. The stock trades about -0.3 of its potential returns per unit of risk. The Shanghai Rightongene Biotechnology is currently generating about -0.13 of returns per unit of risk over similar time horizon. If you would invest  2,085  in Shanghai Rightongene Biotechnology on October 10, 2024 and sell it today you would lose (273.00) from holding Shanghai Rightongene Biotechnology or give up 13.09% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	95.45%
Values	Daily Returns

Wuhan Yangtze Communication  vs.  Shanghai Rightongene Biotechno

Wuhan Yangtze Commun

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Wuhan Yangtze Communication are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Wuhan Yangtze sustained solid returns over the last few months and may actually be approaching a breakup point.

Shanghai Rightongene

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Shanghai Rightongene Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Shanghai Rightongene is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Wuhan Yangtze and Shanghai Rightongene

The main advantage of trading using opposite Wuhan Yangtze and Shanghai Rightongene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Wuhan Yangtze position performs unexpectedly, Shanghai Rightongene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanghai Rightongene will offset losses from the drop in Shanghai Rightongene's long position.

The idea behind Wuhan Yangtze Communication and Shanghai Rightongene Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.